Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10046512HBVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30086165HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30037769HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007173HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007241HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20045839HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS44041826HTLV-1ENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TCGA Plot Options
Drug Information
GeneCHRM5
DrugBank IDDB00572
Drug NameAtropine
Target IDBE0000247
UniProt IDP08912
Regulation Typeantagonist
PubMed IDs7855217; 22222705; 1323653
CitationsCusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65.@@Buels KS, Fryer AD: Muscarinic receptor antagonists: effects on pulmonary function. Handb Exp Pharmacol. 2012;(208):317-41. doi: 10.1007/978-3-642-23274-9_14.@@Wall SJ, Yasuda RP, Li M, Ciesla W, Wolfe BB: Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration. J Pharmacol Exp Ther. 1992 Aug;262(2):584-8.
GroupsApproved; Vet_approved
Direct ClassificationTropane alkaloids
SMILESCN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1
Pathways
PharmGKBPA448505
ChEMBLCHEMBL517712